GSK won the latest trial over claims that discontinued heartburn drug Zantac caused cancer, as a jury on Monday found that the drug was not responsible for an Illinois woman's illness, a company ...

GSK has won its latest trial over whether its former best-selling drug caused cancer on Monday, after a jury found it was not the root cause of an American woman’s illness. Carrie Joiner had alleged ...

Zantac manufacturers notched a massive win in court in 2022 when a Florida district judge rejected the science backing the claims that it could cause cancer. The ruling freed the drugmakers from ...

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

UK-based GlaxoSmithKline PLC (GB:GSK) has won the latest U.S. trial concerning its heartburn drug Zantac (ranitidine), amid litigation over alleged cancer risks. The Florida State Court ruled in ...

This month in the Zantac litigation, the Delaware Supreme Court tossed all the plaintiffs’ experts in thousands of cases, ...

But the biggest win so far came in December when a U.S. District Judge wiped thousands of federal claims from GSK, Sanofi, Pfizer and Boehringer Ingelheim’s plates, ruling that the science used ...

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK (GSK.L), opens new tab and other companies, causes cancer is set to begin this week in ...

Delaware’s top court ruled in GSK’s favor in saying it will review the admissibility of expert evidence in an upcoming trial over possible cancer risks from its Zantac heartburn remedy ...

GSK Plc convinced an Illinois jury that the former heartburn drug Zantac was not liable for a woman’s colorectal cancer in a second trial win for the British drugmaker.. It comes just over two ...

(Reuters) - GSK won the latest trial over claims that discontinued heartburn drug Zantac caused cancer, as a jury on Monday found that the drug was not responsible for an Illinois woman's illness ...